📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study. (2018)

First Author: Herrington WG

Attributed to: Adiposity and kidney disease: observations from large blood-based prospective cohorts across a wide range of different populations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ckj/sfy090

PubMed Identifier: 30524708

Publication URI: http://europepmc.org/abstract/MED/30524708

Type: Journal Article/Review

Volume: 11

Parent Publication: Clinical kidney journal

Issue: 6

ISSN: 2048-8505